Adherence to Pre-exposure Prophylaxis in Black Men Who Have Sex with Men and Transgender Women in a Community Setting in Harlem, NY

• DOI: 10.1007/s10461-020-02901-6
• Publication Date: 2020-05-08T12:02:45Z
• Authors: P. W. Colson; J. Franks; Y. Wu; F. S. Winterhalter; J. Knox; H. Ortega; W. M. El-Sadr; Y. Hirsch-Moverman
• Keywords: Male; Anti-HIV Agents; New York; HIV Infections; Transgender Persons; Medication Adherence; 3. Good health; Black or African American; 03 medical and health sciences; 0302 clinical medicine; Humans; Female; Pre-Exposure Prophylaxis; Homosexuality, Male

While oral pre-exposure prophylaxis (PrEP) has proven efficacious for HIV prevention, consistent use is necessary to achieve its intended impact. We compared effectiveness of enhanced PrEP (enPrEP) adherence support to standard of care (sPrEP) among Black MSM and TGW attending a community clinic in Harlem, NY. EnPrEP included peer navigation, in-person/online support groups, and SMS messages. Self-reported adherence over previous 30 days, collected in quarterly interviews, was defined as ≥ 57%. Crude and adjusted analyses examined factors associated with adherence. A total of 204 participants were enrolled and randomized; 35% were lost to follow-up. PrEP adherence was 30% at 12-months; no intervention effect was observed (p = 0.69). Multivariable regression analysis found that lower adherence was associated with low education and depressive symptoms. We found that an enhanced adherence intervention did not improve PrEP adherence. Findings point to the need for innovative methods to improve PrEP adherence among Black MSM and TGW.Clinical Trial Registration NCT02167386, June 19, 2014.